Selected Publications 

2006

Segal BH, Kwon-Chung J, Walsh TJ, Klein BS, Battiwalla M, Almyroudis NG, Holland SM, and Romani L.  Immunotherapy for Fungal Infections.  Clin. Infectious Diseases.  42: 507-15, 2006.

Elefante A, Muindi J, West K, Dunford L, Abel S, Paplham P, Brown K, Hahn T, Padmanabhan S, Battiwalla M, and McCarthy PL.  Long-term stability of a patient-convenient 1mg.ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels.  Bone Marrow Transplantation. 2006 March 6 [Epub ahead of print].

Dunford LM, Roy DM, Hahn TE, Padmanabhan S, Segal BH, Almyroudis N, McCarthy PL Jr., and Battiwalla M.  Dapsone-induced methemoglobinemia after hematopoietic stem cell transplantation.  Biology of Blood and Marrow Transplantation.  12(2):241-2, 2006.  (no abstract available)

Tallman MS, Perez WS, Lazarus HM, Gale RP, Maziarz RT, Rowe JM, Marks DI, Cahn JY, Bashey A, Bishop MR, Christiansen N, Frankel SR, Garcia JJ, Ilhan O, Laughlin MJ, Liesveld J, Linker C, Litzow MR, Luger S, McCarthy PL, Milone GA, Pavlovsky S, Phillips GL, Russell JA, Saez RA, Schiller G, Sierra J, Weiner RS, Zander AR, Zhang MJ, Keating A, Weisdorf DJ, and Horowitz MM.  Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.  Biology of Blood and Marrow Transplantation.  12(2): 204-16. 2006.

Hahn T, Wall D, Camitta B, Davies S, Dillon H, Gaynon P, Larson RA, Parsons S, Seidenfeld F, Weisdorf D, and McCarthy PL Jr.  The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults:  an evidence-based review.  Biology of Blood and Marrow Transplantation.  12(1): 1-30, 2006.

Battiwalla M, Hahn T, Radovic M, Roy H, Wahab A, Duman E, Bajwa R, Padmanabhan S, Becker J, Barrett AJ, and McCarthy PL.  Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence.  Blood. 107(5): 1970-3, 2006.

2005

Iyer RV, Hahn T, Roy HN, Battiwalla M, Cooper M, Anderson B, Paplham P, Brown K, Bambach B, Segal BH, and McCarthy PL, Jr.  Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease. Biology of Blood and Marrow Transplantation. 11(8): 587-92, 2005.

Hahn T, Wall D, Camitta B, Davies S, Dillon H, Gaynon P, Larson RA, Parsons S, Seidenfeld J, Weisdorf D, and McCarthy PL Jr. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review.  Biology of Blood and Marrow Transplantation. 11(11): 823-61, 2005.

Ramanarayanan J, Dunford LM, Baer MR, Sait SN, Lawrence W, and McCarthy PL.  Chronic myeloid leukemia after treatment of lymphoid malignancies: Response to imatinib mesylate and favorable outcomes in three patients.  Leukemia Research. 2005 Dec. 2 [Epub ahead of print].

Oh H, Loberiza Jr FR, Zhang MJ, Ringden O, Akiyama H, Asai T, Miyawaki S, Okamoto S, Horowitz MM, Antin JH, Bashey A, Bird JM, Carabasi MH, Fay JW, Gale RP, Giller RH, Goldman JM, Hale GA, Harris RE, Henslee-Downey J, Kolb HJ, Litzow MR, McCarthy PL, Neudorf SM, Serna DS, Socie G, Tiberghien P, Barrett AJ.  Comparison of graft-vs-host-disease and survival after HLA-identical sibling bone marrow transplantation in different ethnic populations.  Blood. 105: 1408-16, 2005.

Hahn T, Benekli B, Wong C, Moysich KB, Hyland A, Michalek AM, Alam A, Baer MR, Bambach B, Czuczman MS, Wetzler M, Becker JL, McCarthy Jr PL. A Prognostic Model for Prolonged Event-Free Survival After Autologous or Allogeneic Blood or Marrow Transplantation for Relapsed and Refractory Hodgkin’s Disease. Bone Marrow Transplantation, 35 (6): 557-66, 2005.

Shaukat A, Bakri F, Young P, Hahn T, Ball D, Baer M, Wetzler M, Slack J, Loud P, Czuczman C, McCarthy P, Walsh T, Segal B. Invasive filamentous fungal infections in allogenic hematopoietic stem cell transplant recipients after recovery from neutropenia: clincial, radiologic, and pathologic characteristics. Mycopathologia. 159 (2):181-8, 2005.

Scarpace SL, Hahn, Roy H, Brown K, Paplham P, Chanan-Khan A, van Besien K, McCarthy PL. Arterial Thrombosis In Four Patients Treated With Thalidomide. Leukemia and Lymphoma. 46(2): 239-42, 2005.

2004

Hahn T, Alam AR, Lawrence D Ford LA, Baer MR, Bambach B, Bernstein ZP, Czuczman MS, Silva J, Slack JL, Wetzler M, Becker J, McCarthy Jr PL. Thrombotic Microangiopathy After Allogeneic Blood and Marrow Transplantation is Associated with Dose Intensive Myeloablative Conditioning Regimens, Unrelated Donor and Methylprednisolone T Cell-Depletion, Transplantation. 78 (10): 1515-22, 2004.

Mahoney MC, Moysich KM, McCarthy PL, McDonald RC, Stepanenko VF, Day RW, Michalek AM. The Chernobyl childhood leukemia study: background & lessons learned. Environmental Health: A Global Access Science Source 2004, 3:12 (8Nov2004)

Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Perez WS, Anasetti C, Bolwell BJ, Cairo MS, Gale RP, Klein JP, Lazarus HM, Liesveld JL, McCarthy PL, Milone GA, Rizzo JD, Schultz KR, Trigg ME, Keating A, Weisdorf DJ, Antin JH, Horowitz MM. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low risk myelodysplasia is associated with improved outcome. Blood.104:579-85, 2004.

Lee SJ, Zahrieh D, Agura E, MacMillan ML, Maziarz RT, McCarthy PL, Ho VT, Cutler C, Alyea EP, Antin JH, Soiffer RJ. Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-vs.-host disease: results of a randomized trial. Blood. 104 (5): 1559-64, 2004.

Freytes CO, Loberiza FR, Rizzo JD, Bashey A, Bredeson CN, Cairo MS, Gale RP, Horowitz MM, Klumpp TR, Martino R, McCarthy PL, Molina A, Pavlovsky S, Pecora AL, Serna DS, Tsai T, Zhang MJ, Vose JM, Lazarus HM, Van Besien K. Myeloablative allogeneic hematopoietic stem cell transplantation in patients who relapse after autologous stem cell transplantation for lymphoma: a report of the international bone marrow transplant registry. Blood, 104 (12): 3797-803, 2004.

Chanan-Khan A, Islam T, Alam A, Miller KC, Gibbs J, Barcos M, Czuczman MS, Paplham P, Hahn T, McCarthy P.  Long-term survival with allogeneic stem cell transplant following salvage therapy with anti-CD52 monoclonal antibody (Campath®) in a patient with á/â hepatosplenic T-cell non-Hodgkin’s lymphoma.  Leukemia & Lymphoma.  45:1673-1675, 2004.

Mahoney MC, Lawvere S, Falkner KL, Averkin YI, Ostapenko VA, Michalek AM Moysich KB, McCarthy PL. Thyroid cancer incidence trends in Belarus: examining the impact of Chernobyl. Int Journal Epidemiology. 33(5): 1025-33, 2004.

McCarthy Jr PL, Paltiel O, Maslova E, Kulikov S, Hahn T, Kopecky KJ, Drozdova V, Shmatina N, Tichonova L, Van Hoff J, Gavrilova I, Weinstein W,  Histopathologic Verification of Acute Leukemia (AL) in a Cohort of 463 Post-Chernobyl Patients from Belarus, Russia and Ukraine. Leukemia Research 2004 Dec;28(12):1273-1280. (Corrected Proof, Available online 1 July 2004)

2003
Reece DE, Bredeson C, Perez WS, Jagannath S, Zhang MJ, Ballen KK, Elfenbein GJ, Freytes CO, Gale RP, Gertz MA, Gibson J, Giralt SA, Keating A, Kyle RA, Maharaj D, Marcellus D, McCarthy PL, Milone GA, Nimer SD, Pavlovsky S, To LB, Weisdorf DJ, Wiernik PH, Wingard JR, Vesole DH. Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age. Bone Marrow Transplant 32:1135-1143, 2003.

Hahn T, Wolff SN, Czuczman M, Fisher RI, Lazarus HM, McCarthy PL, Vose J, Warren L, Watt R; American Society for Blood and Marrow Transplantation (ASBMT).  The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin's lymphoma.  Biol. Blood and Marrow Transplant.  9(10): 667, 2003. (no abstract available)

Hahn T, Rondeau C, Shaukat A, Jupudy V, Miller A, Alam AR, Baer MR, Bambach B, Bernstein Z, Chanan-Khan AA, Czuczman MS, Slack J, Wetzler M, Mookerjee BK, Silva J, and McCarthy PL Jr.  Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients.  Bone Marrow Transplant. 32(4): 405-10, 2003.

2002
Berry DA, Broadwater G, Klein JP, Antman K, Aisner J, Bitran J, Costanza M, Freytes CO, Stadtmauer E, Gale RP, Henderson IC, Lazarus HM, McCarthy PL Jr, Norton L, Parnes H, Pecora A, Perry MC, Rowlings P, Spitzer G, Horowitz MM. High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the autologous blood and marrow transplant registry. J Clin Oncol 20(3):743-750, 2002.

Czuczman MS, Fallon A, Mohr A, Stewart C, Bernstein ZP, McCarthy P, Skipper M, Brown K, Miller K, Wentling D, Klippenstein D, Loud P, Rock MK, Benyunes M, Grillo-Lopez AJ, Bernstein SH. Rituximab in combination with CHOP or Fludarabine in low-grade lymphoma. Seminars in Oncology 29(1) (suppl 2): 36-40, 2002.

Weisdorf D, Bishop M, Dharan B, Bolwell B, Cahn JY, Caziro M, Giralt S, Klein J, Lazarus H, Litzow M, Marks D, McCarthy P, Miller C, Milone G, Russell J, Schultz KR, Sierra J, Wiernik P, Keating A, Loberiza F, Kollman C, Horowitz, M. Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes. Biology of Blood and Marrow Transplant 8:213-220, 2002.

Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY, Carabasi MH, Gale RP, Giralt S, Hale GA, Ilhan O, McCarthy PL, Socie G, Verdonck LF, Weisdorf DJ, Horowitz MM. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood. 2002 Jul 15;100(2):406-14

Zamostian P, Moysich KB, Mahoney MC, McCarthy P, Bondar AY, Noschenko AG, Michalek AR. Influence of various factors on individual radiation exposure from the Chernobyl disaster. Environmental Health: A Global Access Science Source 1:4, 2002. Available from: http://www.ehjournal.net

Earlier Publications
van Besien K, Sobocinski KA, Rowlings PA, Murphy SC, Armitage JO, Bishop MR, Chaekal OK, Gale RP, Klein JP, Lazarus HM, McCarthy Jr PL, Raemaekers JM, Reiffers J, Phillips GL, Schattenberg AV, Verdonck LF, Vose JM, Horowitz MM. Allogeneic Bone Marrow Transplantation for Low Grade Lymphoma. Blood 92:1832-1836, 1998.

Antman KH, Rowlings PA, Vaughn WP, Pelz CJ, Fay JW, Fields KK, Freytes CO, Gale RP, Hillner B, Holland HK, Kennedy MJ, Klein JP, Lazarus HM, McCarthy Jr PL, Saez R, Spitzer GL, Stadtmauer EA, Williams SF, Wolff S, Sobocinski KA, Armitage JO, Horowitz MM. High-Dose Chemotherapy with Autologous Hematopoietic Stem-Cell Support for Breast Cancer in North America. J Clin Oncol 15:1870-1879, 1997.

Gajewski JL, Phillips GL, Sobocinski KA, Armitage JO, Gale RP, Champlin RE, Herzig RH, Hurd DD, Jagannath S, Klein JP, Lazarus HM, McCarthy PL, Pavlovsky S, Petersen FB, Rowlings PA, Russell JA, Silver SM, Vose JM, Wiernik PH, Bortin MM, Horowitz MM. Bone Marrow Transplants from HLA-Identical Siblings in Advanced Hodgkin Disease. J Clin Oncol 14:572-578, 1996.

van Besien KW, Mehra RC, Giralt SA, Kantarjian HM, Pugh WC, Khouri IF, Moon Y, Williams P, Andersson BS, Przepiorka D, McCarthy PL, Gajewski JL, Deisseroth AB, Cabanillas FF, Champlin R. Allogeneic Bone Marrow Transplantation for Poor-Prognosis Lymphoma - Response, Toxicity, and Survival Depend on Disease Histology. Am J Med 100:299-307, 1996.

van Besien KW, Khouri IF, Giralt SA, McCarthy P, Mehra R, Andersson BS, Przepiorka D, Gajewski JL, Bellare N, Nath R, Romaguera JE, McLauglin PW, Korbling M, Deisseroth AB, Cabanillas FF, Champlin RE. Allogeneic Bone Marrow Transplantation for Refractory and Recurrent Low Grade Lymphoma: The Case for Aggressive Management. J Clin Oncol 13:1096-1102, 1995.